{"id":76552,"date":"2026-08-25T16:20:05","date_gmt":"2026-08-25T08:20:05","guid":{"rendered":"https:\/\/flcube.com\/?p=76552"},"modified":"2026-08-25T16:20:06","modified_gmt":"2026-08-25T08:20:06","slug":"merck-loses-third-circuit-appeal-as-court-upholds-medicare-drug-price-negotiations-under-ira","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=76552","title":{"rendered":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <strong>U.S. Court of Appeals for the Third Circuit<\/strong> ruled against <strong>Merck &amp; Co., Inc.<\/strong> (MSD; <a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/MRK:NYSE\">NYSE: MRK<\/a>), rejecting the drugmaker&#8217;s claim that <strong>Medicare drug price negotiations<\/strong> violate the <strong>First and Fifth Amendments<\/strong>. The decision lands just five days after a federal court in Maryland dismissed an <strong>AstraZeneca<\/strong> lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.<\/p>\n\n\n\n<h2 id=\"h-ruling-summary\" class=\"wp-block-heading\">Ruling Summary<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Court<\/strong><\/td><td>U.S. Court of Appeals for the Third Circuit<\/td><\/tr><tr><td><strong>Plaintiff<\/strong><\/td><td>Merck &amp; Co., Inc. (MSD; NYSE: MRK)<\/td><\/tr><tr><td><strong>Claim<\/strong><\/td><td>Medicare drug price negotiations violate First and Fifth Amendments<\/td><\/tr><tr><td><strong>Ruling<\/strong><\/td><td>Rejected<\/td><\/tr><tr><td><strong>Ruling Date<\/strong><\/td><td>24 Aug 2026<\/td><\/tr><tr><td><strong>Related Ruling<\/strong><\/td><td>19 Aug 2026 \u2013 Federal court in Maryland dismissed AstraZeneca&#8217;s drug\u2011grouping challenge<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-a-pattern-of-legal-defeats\" class=\"wp-block-heading\">A Pattern of Legal Defeats<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Inflation Reduction Act (IRA) Origins:<\/strong> The Medicare drug price negotiation program was introduced under the <strong>IRA in 2022<\/strong>, and drugmakers have mounted repeated constitutional and procedural challenges since.<\/li>\n\n\n\n<li><strong>Supreme Court Declined to Intervene:<\/strong> In May, the <strong>U.S. Supreme Court declined to hear<\/strong> cases brought by <strong>Johnson &amp; Johnson, Bristol\u2011Myers Squibb, Novo Nordisk, Novartis, Boehringer Ingelheim<\/strong> and a previous <strong>AstraZeneca<\/strong> lawsuit, after lower courts had rejected all challenges.<\/li>\n\n\n\n<li><strong>Cumulative Effect:<\/strong> The latest Third Circuit loss adds to an unbroken series of defeats for the industry&#8217;s attempts to block or reshape the negotiation framework through the courts.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-teva-secures-rare-partial-win\" class=\"wp-block-heading\">Teva Secures Rare Partial Win<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Generic Drug Exclusion Case:<\/strong> Last week, <strong>Teva<\/strong> secured a rare partial win, with a federal appeals court sending a <strong>generic drug exclusion case back to District Court<\/strong> for further review.<\/li>\n\n\n\n<li><strong>Austedo Classification Rejected:<\/strong> However, the court rejected Teva&#8217;s separate challenge regarding the classification of its Huntington&#8217;s disease drugs <strong>Austedo and Austedo XR as a single product<\/strong> \u2014 a determination that affects how negotiation eligibility is assessed.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-industry-implications-amp-outlook\" class=\"wp-block-heading\">Industry Implications &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Legal Avenues Narrowing:<\/strong> With the Supreme Court already declining review and the Third Circuit now affirming the program&#8217;s constitutionality, pharmaceutical companies have few remaining judicial paths to overturn IRA\u2011based Medicare negotiations.<\/li>\n\n\n\n<li><strong>Pricing Pressure Persists:<\/strong> The rulings cement a structural headwind on pricing for blockbuster drugs that reach negotiation eligibility, reinforcing the importance of pipeline renewal and lifecycle management strategies.<\/li>\n\n\n\n<li><strong>Focus Shifts to Policy:<\/strong> With courts largely out of the picture, industry attention is expected to pivot toward legislative and administrative efforts to soften the program&#8217;s implementation details.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the implications of the Third Circuit ruling and related litigation for pharmaceutical pricing and company financial outlooks. Actual outcomes may differ due to risks including further appeals, legislative developments and administrative decisions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Court of Appeals for the Third Circuit ruled against Merck &amp; Co., Inc&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,61],"tags":[130,390,428,149,120,2675,176,140,148,903],"class_list":["post-76552","post","type-post","status-publish","format-standard","hentry","category-company","category-legal-ip","tag-astrazeneca","tag-boehringer-ingelheim","tag-bristol-myers-squibb","tag-johnson-johnson","tag-merck","tag-merck-sharp-dohme","tag-msd","tag-novartis","tag-novo-nordisk","tag-nyse-mrk"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The U.S. Court of Appeals for the Third Circuit ruled against Merck &amp; Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker&#039;s claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=76552\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA\" \/>\n<meta property=\"og:description\" content=\"The U.S. Court of Appeals for the Third Circuit ruled against Merck &amp; Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker&#039;s claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=76552\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-25T08:20:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-25T08:20:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA\",\"datePublished\":\"2026-08-25T08:20:05+00:00\",\"dateModified\":\"2026-08-25T08:20:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552\"},\"wordCount\":448,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AstraZeneca\",\"Boehringer Ingelheim\",\"Bristol-Myers Squibb\",\"Johnson &amp; Johnson\",\"Merck\",\"Merck Sharp &amp; Dohme\",\"MSD\",\"Novartis\",\"Novo Nordisk\",\"NYSE: MRK\"],\"articleSection\":[\"Company\",\"Legal \\\/ IP\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=76552#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=76552\",\"name\":\"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-25T08:20:05+00:00\",\"dateModified\":\"2026-08-25T08:20:06+00:00\",\"description\":\"The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=76552\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76552#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA - Insight, China&#039;s Pharmaceutical Industry","description":"The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=76552","og_locale":"en_US","og_type":"article","og_title":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA","og_description":"The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.","og_url":"https:\/\/flcube.com\/?p=76552","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-25T08:20:05+00:00","article_modified_time":"2026-08-25T08:20:06+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=76552#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=76552"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA","datePublished":"2026-08-25T08:20:05+00:00","dateModified":"2026-08-25T08:20:06+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=76552"},"wordCount":448,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AstraZeneca","Boehringer Ingelheim","Bristol-Myers Squibb","Johnson &amp; Johnson","Merck","Merck Sharp &amp; Dohme","MSD","Novartis","Novo Nordisk","NYSE: MRK"],"articleSection":["Company","Legal \/ IP"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=76552#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=76552","url":"https:\/\/flcube.com\/?p=76552","name":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-25T08:20:05+00:00","dateModified":"2026-08-25T08:20:06+00:00","description":"The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First and Fifth Amendments. The decision lands just five days after a federal court in Maryland dismissed an AstraZeneca lawsuit alleging improper drug grouping for negotiation eligibility \u2014 extending a string of judicial defeats for pharmaceutical companies challenging the program.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=76552#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=76552"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=76552#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=76552"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76552\/revisions"}],"predecessor-version":[{"id":76553,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76552\/revisions\/76553"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=76552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=76552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=76552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}